Schering-Plough
SGP
#544
Rank
C$63.37 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: C$2.81 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of C$2.81 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008C$2.81 B
2006C$2.03 B198.39%
2005C$0.68 B-395.83%
2004-C$0.24 Billion265.22%
2003-C$63.12 Million-102.01%
2002C$3.14 B3.62%
2001C$3.03 B-5.39%
2000C$3.20 B
1998C$2.64 B22.34%
1997C$2.16 B38.9%
1996C$1.55 B